HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.

Abstract
To date, a number of potential biomarkers for lung squamous cell cancer (SCC) have been identified; however, sensitive biomarkers are currently lacking to detect early stage SCC due to low sensitivity and specificity. In the present study, we compared the 7 serum proteomic profiles of 11 SCC patients, 7 chronic obstructive pulmonary disease (COPD) patients and 7 healthy smokers as controls to identify potential serum biomarkers associated with SCC and COPD. Two-dimensional difference gel electrophoresis (2D-DIGE) and mass-spectrometric analysis (MS) using an affinity column revealed two candidate proteins, haptoglobin (HP) and apolipoprotein 4, as biomarkers of SCC, and α-1-antichymotrypsin as a marker of COPD. The iTRAQ technique was also used to identify SCC-specific peptides. HP protein expression was significantly higher in SCC patients than in COPD patients. Furthermore, two HP protein peptides showed significantly higher serum levels in SCC patients than in COPD patients. We established novel polyclonal antibodies for the two HP peptides and subsequently a sandwich enzyme-linked immunosorbent assay (ELISA) for the quantification of these specific peptides in patient and control sera. The sensitivity of detection by ELISA of one HP peptide (HP216) was 70% of SCC patients, 40% of COPDs patients and 13% of healthy controls. We also measured CYFRA, a cytokeratin fragment clinically used as an SCC tumor marker, in all the 28 cases and found CYFRA was detected in only seven SCC cases. However, when the measurement of HP216 was combined with that of CYFRA, 100% (10 of 10 patients) of SCC cases were detected. Our proteomic profiling demonstrates that the SCC-specific HP peptide HP216 may potentially be used as a diagnostic biomarker for SCC.
AuthorsTetsuya Okano, Masahiro Seike, Hidehiko Kuribayashi, Chie Soeno, Takeo Ishii, Kozui Kida, Akihiko Gemma
JournalInternational journal of oncology (Int J Oncol) Vol. 48 Issue 3 Pg. 945-52 (Mar 2016) ISSN: 1791-2423 [Electronic] Greece
PMID26783151 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins A
  • Biomarkers, Tumor
  • Haptoglobins
  • Peptide Fragments
  • Proteome
  • alpha 1-Antichymotrypsin
  • apolipoprotein A-IV
  • haptoglobin (216-228), human
  • Keratins
Topics
  • Adult
  • Aged
  • Apolipoproteins A (blood)
  • Biomarkers, Tumor (blood)
  • Carcinoma, Squamous Cell (blood, diagnosis)
  • Case-Control Studies
  • Electrophoresis, Gel, Two-Dimensional
  • Enzyme-Linked Immunosorbent Assay
  • Haptoglobins (chemistry, metabolism)
  • Humans
  • Keratins (metabolism)
  • Lung Neoplasms (blood, diagnosis)
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Peptide Fragments (chemistry)
  • Proteome (metabolism)
  • Pulmonary Disease, Chronic Obstructive (blood)
  • Smoking
  • alpha 1-Antichymotrypsin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: